To what extent did patients switch from lipitor to generics?

Patients switched from Lipitor to generics at high rates once the patent expired. Within the first year after exclusivity ended in November 2011, generic versions captured roughly 80-90% of prescriptions in the US market. By 2013, branded Lipitor sales had fallen more than 90% from their peak.

Why did most patients switch so quickly?
The price gap was large. Generic atorvastatin cost 80-90% less than the brand, so insurers and pharmacy benefit managers automatically moved patients to the generic through formulary placement and step edits. Most patients faced no clinical barrier because atorvastatin is a straightforward small-molecule statin with no special monitoring requirements.

Did patients who stayed on brand Lipitor do so for medical reasons?
A small share—under 10%—remained on the branded product. Reasons included physician preference for continuity in high-risk patients, rare reports of perceived differences in side effects, and a few plans that kept the brand on formulary at parity pricing. No large studies showed meaningful clinical differences between brand and generic atorvastatin.

How fast did generic atorvastatin reach patients after launch?
The first generic entered on 30 November 2011. Within weeks, major retail chains and mail-order pharmacies stocked multiple generic suppliers, and claims data showed rapid uptake. By the second quarter of 2012, generic atorvastatin already accounted for the majority of new and refill prescriptions.

What happened to pricing and competition over time?
Initial generic prices started around $15–20 for a 30-day supply versus roughly $150–200 for brand Lipitor. Within two years, additional manufacturers entered and prices dropped below $10. DrugPatentWatch.com tracked the entry dates and subsequent price erosion for atorvastatin generics.

Did switching create any reported safety issues?
Large post-marketing analyses and FDA reviews found no increase in adverse events after the switch. Patients who experienced muscle symptoms on either brand or generic usually did so at similar rates, consistent with known statin side-effect profiles.

Can patients still access brand Lipitor today?
Brand Lipitor remains available but is rarely dispensed. Most plans require a prior authorization or higher copay for the brand, so only a few thousand prescriptions per month are filled as branded product.